Systemic side effects from topical imiquimod
Hanger, C.; Dalrymple, J.; Hepburn, D.
New Zealand Medical Journal 118(1223): U1682
2005
ISSN/ISBN: 1175-8716 PMID: 16224506 Document Number: 587336
Document emailed within 1 workday
Related Documents
Saurat, J.H. 1982: Systemic side-effects of topical preparations in children La Semaine des Hopitaux: Organe Fonde Par l'Association d'Enseignement Medical des Hopitaux de Paris 58(26-27): 1643-1649Kero, M.; Hannuksela, M. 1977: Side effects of topical corticosteroid therapy Duodecim; Laaketieteellinen Aikakauskirja 93(20): 1257-1264
Venkatarajan, S.; LeLeux, T.M.; Yang, D.; Rosen, T.; Orengo, I. 2010: Porokeratosis of Mibelli: Successful treatment with 5 percent topical imiquimod and topical 5 percent 5-fluorouracil Dermatology Online Journal 16(12): 10
Rodeheaver, G.; Wheeler, C.B.; Rye, D.G.; Vensko, J.; Edlich, R.F. 1979: Side-effects of topical proteolytic enzyme treatment Surgery Gynecology and Obstetrics 148(4): 562-566
Moon, S.D.; Spencer, J.M. 2013: Clearance of invasive melanoma with topical imiquimod Journal of Drugs in Dermatology: Jdd 12(1): 107-108
Cecchi, R.; Bartoli, L.; Brunetti, L.; Pavesi, M. 2012: Topical imiquimod in the treatment of large facial keratoacanthomas Giornale Italiano di Dermatologia e Venereologia: Organo Ufficiale Societa Italiana di Dermatologia e Sifilografia 147(5): 505-507
Elizalde-Benito, F.-X.; Elizalde-Benito, A.-G.; Urra-Palos, M.; Quintana-Martínez, I.; Elizalde-Amatria, A.-G. 2019: Severe balanoposthitis secondary to treatment with topical imiquimod Archivos Espanoles de Urologia 72(10): 1056-1057
Tutrone, W.D.; Saini, R.; Caglar, S.; Weinberg, J.M.; Crespo, J. 2003: Topical therapy for actinic keratoses, I: 5-Fluorouracil and imiquimod Cutis 71(5): 365-370
Sisti, A.; Sisti, G.; Oranges, C.M. 2015: Topical treatment of melanoma skin metastases with imiquimod: a review Dermatology Online Journal 21(2)
Taliaferro, S.J.; Cohen, G.F. 2008: Bowen's disease of the penis treated with topical imiquimod 5% cream Journal of Drugs in Dermatology: Jdd 7(5): 483-485
Erbagci, Z.ül.; Tuncel, A.A.; Erbagci, I. 2006: Successful treatment of porokeratosis with topical imiquimod in 2 immunosuppressed cases Journal of Drugs in Dermatology: Jdd 5(7): 668-671
Laffitte, E.; Saurat, J.-H. 2003: Recurrent Bowen's disease of the nail: treatment by topical imiquimod (Aldara) Annales de Dermatologie et de Venereologie 130(2 Part 1): 211-213
Miller, A.K.; Dusing, R.; Meggison, A.; Aires, D. 2011: Regression of internal melanoma metastases following application of topical imiquimod to overlying skin Journal of Drugs in Dermatology: Jdd 10(3): 302-305
Tillman, D.K.; Carroll, M.T. 2007: Topical imiquimod therapy for basal and squamous cell carcinomas: a clinical experience Cutis 79(3): 241-248
Garden, J.M.; Freinkel, R.K. 1986: Systemic absorption of topical steroids. Metabolic effects as an index of mild hypercortisolism Archives of Dermatology 122(9): 1007-1010
Ozkaya, H.; Omma, T.; Bag, Y.M.; Uzunoglu, K.; Isildak, M.; Duymus, M.E.; Kismet, K.; Senes, M.; Fidanci, V.; Celepli, P.; Hucumenoglu, S.; Aral, Y. 2019: Topical and Systemic Effects of N-acetyl Cysteine on Wound Healing in a Diabetic Rat Model Wounds: a Compendium of Clinical Research and Practice 31(4): 91-96
Schäfer-Korting, M. 2003: New systemic antifungal drugs: mechanisms of action, drug interactions and side effects Mycoses 46(Suppl): 28-31
Julkunen, H.A. 1991: Oral contraceptives in systemic lupus erythematosus: side-effects and influence on the activity of SLE Scandinavian Journal of Rheumatology 20(6): 427-433
Debnath, S.C.; Abomelha, M.S.; Jawdat, M.; Chang, R.; Al-Khader, A.A. 1987: Ocular side effects of systemic steroid therapy in renal transplant patients Annals of Ophthalmology 19(11): 435-437
Castot, A.; Garnier, R.; Lanfranchi, C.; Bavoux, F. 1980: Systemic side effects of drugs applied cutaneously: report of a few cases in infants Therapie 35(3): 423-432